Q4 2016 Holdings
Filed 2017-02-14 | 64 holdings | $40.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Angiodynamics Inc(ANGO) | COM | 03475V101 | $24.8M | 1,471,152 | 62.1% |
| Catalyst Pharmaceuticals Inc(CPRX) | COM | 14888U101 | $8.6M | 8,200,000 | 21.5% |
| Adma Biologics Inc(ADMA) | COM | 000899104 | $5.7M | 1,113,293 | 14.3% |
| Horizon Pharma PLC | SHS | G4617B105 | $96.4K | 5,959,819 | 0.2% |
| Progenics Pharmaceuticals in | COM | 743187106 | $77.3K | 8,951,169 | 0.2% |
| Retrophin Inc | COM | 761299106 | $61.9K | 3,269,271 | 0.2% |
| Heron Therapeutics Inc(HRTX) | COM | 427746102 | $51.1K | 3,899,587 | 0.1% |
| Flamel Technologies SA | SPONSORED ADR | 338488109 | $45.7K | 4,394,464 | 0.1% |
| Antares Pharma Inc(ATRSEUR) | COM | 036642106 | $30.2K | 12,971,093 | 0.1% |
| Aratana Therapeutics Inc(PETXEUR) | COM | 03874P101 | $26.5K | 3,695,442 | 0.1% |
| LA Jolla Pharmaceutical Co(LJPC) | COM PAR $.0001 2 | 503459604 | $26.5K | 1,510,316 | 0.1% |
| Endo Intl PLC | SHS | G30401106 | $25.7K | 1,560,038 | 0.1% |
| Recro Pharma Inc | COM | 75629F109 | $25.0K | 3,100,086 | 0.1% |
| Teva Pharmaceutical Inds LTD(TEVA) | ADR | 881624209 | $23.5K | 647,500 | 0.1% |
| Aralez Pharmaceuticals Inc | COM | 03852X100 | $21.1K | 4,791,590 | 0.1% |
| Lion Biotechnologies Inc | COM | 53619R102 | $18.3K | 2,638,259 | 0.0% |
| Aevi Genomic Medicine Inc(GNMXEUR) | COM | 00835P105 | $17.5K | 3,370,306 | 0.0% |
| Novelion Therapeutics Inc | COM NEW | 67001K202 | $16.4K | 1,948,554 | 0.0% |
| Medicines Co | COM | 584688105 | $14.8K | 436,400 | 0.0% |
| Veracyte Inc(VCYT) | COM | 92337F107 | $13.8K | 1,788,266 | 0.0% |
| Derma Sciences Inc | COM PAR $.01 | 249827502 | $13.3K | 2,562,104 | 0.0% |
| Horizon Pharma PLCCall | SHS | G4617B105 | $12.9K | 800,000 | 0.0% |
| Teligent Inc New | COM | 87960W104 | $12.8K | 1,931,711 | 0.0% |
| Acorda Therapeutics Inc | COM | 00484M106 | $12.1K | 644,153 | 0.0% |
| Paratek Pharmaceuticals Inc | COM | 699374302 | $12.1K | 786,134 | 0.0% |
| Ignyta Inc | COM | 451731103 | $12.0K | 2,256,546 | 0.0% |
| Durect Corp(DRRXEUR) | COM | 266605104 | $11.4K | 8,506,229 | 0.0% |
| Advaxis Inc | COM NEW | 007624208 | $10.9K | 1,519,259 | 0.0% |
| Biodelivery Sciences Intl in(BDSIUSD) | COM | 09060J106 | $9.4K | 5,398,794 | 0.0% |
| Zogenix Inc | COM NEW | 98978L204 | $9.3K | 766,412 | 0.0% |
| Bard C R Inc(BCRUSD) | COM | 067383109 | $9.0K | 40,200 | 0.0% |
| Egalet Corp | NOTE 5.500% 4/0 | 28226BAB0 | $8.9K | 10,000,000 | 0.0% |
| Amarin Corp PLC | SPONS ADR NEW | 023111206 | $8.7K | 2,833,649 | 0.0% |
| Seaspine Hldgs Corp(SPNEUSD) | COM | 81255T108 | $8.7K | 1,100,007 | 0.0% |
| Zimmer Biomet Hldgs Inc(ZBH) | COM | 98956P102 | $8.6K | 83,500 | 0.0% |
| Endologix Inc | COM | 29266S106 | $8.6K | 1,500,000 | 0.0% |
| Corium Intl Inc | COM | 21887L107 | $7.8K | 1,919,721 | 0.0% |
| Strongbridge Biopharma PLC | SHS USD | G85347105 | $6.9K | 2,894,581 | 0.0% |
| Idera Pharmaceuticals Inc | COM NEW | 45168K306 | $6.6K | 4,427,745 | 0.0% |
| Cidara Therapeutics Inc | COM | 171757107 | $5.9K | 562,875 | 0.0% |
| Medtronic PLC(MDT) | SHS | G5960L103 | $5.3K | 75,000 | 0.0% |
| Pacira Pharmaceuticals Inc(PCRX) | COM | 695127100 | $4.9K | 150,680 | 0.0% |
| Glaukos Corp(GKOS) | COM | 377322102 | $4.8K | 141,300 | 0.0% |
| Pacira Pharmaceuticals Inc(PCRX)Call | COM | 695127100 | $4.8K | 150,000 | 0.0% |
| Scynexis Inc | COM | 811292101 | $4.7K | 1,477,273 | 0.0% |
| Alcobra LTD | SHS | M2239P109 | $4.3K | 2,057,106 | 0.0% |
| Aviragen Therapeutics Inc | COM | 053761102 | $4.3K | 3,486,711 | 0.0% |
| Egalet Corp | COM | 28226B104 | $4.3K | 556,233 | 0.0% |
| Nexvet Biopharma PUB LTD Co | ORD SHS | G6503X109 | $4.2K | 1,127,200 | 0.0% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $3.9K | 826,001 | 0.0% |